Qingdao Baheal Medical INC. (SHE:301015)
23.98
+0.05 (0.21%)
At close: Feb 6, 2026
SHE:301015 Revenue
Qingdao Baheal Medical INC. had revenue of 1.88B CNY in the quarter ending September 30, 2025, a decrease of -12.85%. This brings the company's revenue in the last twelve months to 7.58B, down -9.95% year-over-year. In the year 2024, Qingdao Baheal Medical INC. had annual revenue of 8.09B, down -1.96%.
Revenue (ttm)
7.58B
Revenue Growth
-9.95%
P/S Ratio
1.66
Revenue / Employee
2.47M
Employees
3,064
Market Cap
12.60B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 8.09B | -161.54M | -1.96% |
| Dec 31, 2023 | 8.26B | 746.38M | 9.94% |
| Dec 31, 2022 | 7.51B | 458.05M | 6.50% |
| Jan 1, 2022 | 7.05B | 1.17B | 19.94% |
| Dec 31, 2020 | 5.88B | 1.03B | 21.26% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Pharmaceuticals Holding | 280.69B |
| Jointown Pharmaceutical Group | 157.71B |
| C.Q. Pharmaceutical Holding | 83.08B |
| Guangzhou Baiyunshan Pharmaceutical Holdings Company | 77.54B |
| China National Accord Medicines Corporation | 73.04B |
| China National Medicines Corporation | 51.95B |
| China Meheco Group | 33.23B |
| Guangxi LiuYao Group | 20.95B |